Issue 25, 2013

X-ray triggered release of doxorubicin from nanoparticledrug carriers for cancer therapy

Abstract

Enhanced cellular toxicity was observed using X-ray irradiated nanoparticle drug carriers (NDC) consisting of doxorubicin (DOX) conjugated to DNA strands attached to the surface of gold nanoparticles. Kinetic studies showed that X-rays, acting as a triggering modality, generated reactive oxygen species to break DNA strands and release DOX.

Graphical abstract: X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
09 Nov 2012
Accepted
06 Feb 2013
First published
20 Feb 2013

Chem. Commun., 2013,49, 2545-2547

X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy

Z. B. Starkewolf, L. Miyachi, J. Wong and T. Guo, Chem. Commun., 2013, 49, 2545 DOI: 10.1039/C3CC38100E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements